Clinical Trial Details

EORTC-62022

Back to Clinical Trials Database

Phase 2 study of Iressa (ZD 1839) in locally advanced and/or metastatic synovial sarcoma expressing HER1/EGFRI.

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 28-Oct-2002
Date Step1 close: 18-Oct-2005
Date Step2 close: 18-Oct-2005
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 44
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/NCT00052754
NCT number NCT00052754